Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumours use to cripple immune cells and impede their attack—blocking the...
Vous n'êtes pas connecté
Immunotherapies that mobilise a patient’s immune system to fight cancer have become a treatment pillar. These therapies, including CAR T-cell therapy, have performed well in cancers like leukemias and lymphomas, but the results have been less promising in solid tumours. A team led by researchers from the Penn State College of Medicine has re-engineered immune [...]
Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumours use to cripple immune cells and impede their attack—blocking the...
Prostate cancer is the second most common cancer in men worldwide. Despite medical advances in recent years, this type of tumour is still...
Researchers at Winship Cancer Institute of Emory University have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a...
In a breakthrough study published in Cell Reports, researchers from Professor Idit Shachar’s laboratory at the Weizmann Institute of Science have...
Invion Therapeutics is deploying little-known – but age-old – photodynamic therapies to tackle a range of solid tumours. ...
Even as cancer remains a leading cause of death globally, bacteria-based cancer therapy presents an exciting and innovative treatment option. Owing to...
A new AI-powered, imaging-based technology that creates accurate three-dimensional models of tumours, veins, and other soft tissue offers a promising...
The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell therapy.
Polyploidy is a state where a cell contains more copies of the genetic material than the usual “diploid” cell, which contains two copies....
Researchers at the University of California San Diego Centre for Epigenomics (C4E), USA, have developed a new technique, called Droplet Hi-C, that...